tiprankstipranks
Trending News
More News >
Lipella Pharmaceuticals, Inc. (LIPO)
OTHER OTC:LIPO
US Market
Advertisement

Lipella Pharmaceuticals, Inc. (LIPO) Revenue

Compare
109 Followers

Lipella Pharmaceuticals, Inc. Revenue

Lipella Pharmaceuticals, Inc. had a revenue of 129.39M in the quarter ending Mar 31, 2025, with 74405.08%. This bring the company's revenue in the last twelve months to 129.78M, Decreased 24096.66%. In the fiscal year ending Dec 31, 2024, Lipella Pharmaceuticals, Inc. had annual revenue of 536.36K with 19.29% growth.
Revenue (ttm)
129.78M
Revenue Growth
P/S Ratio
6.08
Revenue/Employee
$107,271
Employees
5
Market Cap
$3.26M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
536.36K86.74K+19.29%
Dec 31, 2023
449.62K265.46K+144.15%
Dec 31, 2022
184.16K-75.19K-28.99%
Dec 31, 2021
259.35K-702.34K-73.03%
Dec 31, 2020
961.68K266.94K+38.42%
Dec 31, 2019
694.75K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis